Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.
Int Rev Neurobiol
; 165: 35-62, 2022.
Article
in English
| MEDLINE | ID: covidwho-1797348
ABSTRACT
The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD. We then discuss outcomes from COVID-19 in people with PD, specifically risk of hospitalization and mortality. Finally, we discuss specific contributing and confounding factors which may put PD patients at higher or lower risk from COVID-19.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Parkinson Disease
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Int Rev Neurobiol
Year:
2022
Document Type:
Article
Affiliation country:
Bs.irn.2022.03.001
Similar
MEDLINE
...
LILACS
LIS